Learn why Humana's GAAP EPS is declining while adjusted EPS remains stable, exploring one-time charges, accounting rules, and business performance in detail.

Professional content writter since 2010

Why is Humana’s GAAP EPS falling while Adjusted EPS remains stable?

Join this conversation

Sort By

In May 2026, Humana confirmed a revision to its GAAP EPS guidance, lowering it to $8.36 while holding its Adjusted EPS at $9.00. This $0.64 delta is not a sign of operational failure, but rather the "cost of progress."

The primary driver is the company’s Value Creation Initiatives. Humana is currently spending heavily on restructuring its technology footprint and medical coding operations to combat the Star Ratings headwind. These are one-time "reset" costs-severance, asset impairments, and consulting fees-that GAAP requires to be reported, but which do not reflect the day-to-day health of the insurance business. For the long-term investor, the stable $9.00 Adjusted EPS is the North Star, suggesting that the core machine is still generating cash as expected.

Answered by

Answered on05/08/26

John AndrewSeven years turning raw data and complex information into research that is clear, verified, and actually useful.

View Profile

John Andrew is a research analyst and content writer with over 7 years of experience conducting primary and secondary research across multiple industries. He holds a Master of Science in Applied Research Methods from the University of Edinburgh and a Bachelor of Arts in Social Sciences from the University of Manchester — an academic background that gives his writing a structured, evidence-based approach that distinguishes it from opinion-driven content. His content covers data analysis, industry research, policy evaluation, market trends, and cross-sector insights across topics that require depth, accuracy, and a methodical approach to evidence. His work has appeared on platforms including The Conversation, ResearchGate Blog, and Towards Data Science, where he writes for professionals, academics, and informed readers who need content built on verified research — not aggregated summaries of existing commentary. Over 7 years, John has produced research reports and analytical content for organisations across the public and private sectors, covering topics ranging from policy impact assessments to consumer behaviour analysis. He has published 150+ research-driven articles and reports, contributed to peer-reviewed publications, and is a member of the Market Research Society (MRS), UK. Across all his writing, every claim is sourced, every data point is verified against primary research, and no conclusion is drawn without identifying the evidence and its limitations — because research content that does not show its working is not research, it is assertion.

Answered on05/08/26